NCT02555540View on ClinicalTrials.gov

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 24, 2015

Primary Completion Date

December 15, 2015

Study Completion Date

December 15, 2016

Conditions
Prevention of Infections With Bordetella Pertussis
Interventions
BIOLOGICAL

Boostrix

Randomised assignment

BIOLOGICAL

Placebo (Saline)

Randomised assignment

Trial Locations (1)

9000

Center for Vaccinology, Ghent

Sponsors
All Listed Sponsors
collaborator

University of Surrey

OTHER

collaborator

Novartis Vaccines

INDUSTRY

collaborator

Max Planck Institute for Infection Biology

OTHER

collaborator

deCODE genetics

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

collaborator

Innovative Medicines Initiative

OTHER

lead

University Hospital, Ghent

OTHER